De Leiris, Nicolas MD∗,†; Ruggeri, Valentin MSc∗; Riou, Laurent PhD†; Laramas, Mathieu MD‡; Djaileb, Loïc MD∗,†
Author Information
From the ∗Nuclear Medicine Department, CHU Grenoble-Alpes
†INSERM, U1039, Radiopharmaceutiques Biocliniques
‡Oncology Department, CHU Grenoble-Alpes, Grenoble, France.
Received for publication June 8, 2020; revision accepted September 22, 2020.
Conflicts of interest and sources of funding: none declared.
Correspondence to: Nicolas De Leiris, MD, Clinique Universitaire de Médecine Nucléaire, Centre Hospitalier Universitaire Grenoble-Alpes, CS 10217, 38043 Grenoble CEDEX 9, France. E-mail: [email protected].
doi: 10.1097/RLU.0000000000003384
